Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.18K Buy
38
+2
+6% +$246 ﹤0.01% 339
2026
Q1
$4.24K Buy
36
+24
+200% +$3.35K ﹤0.01% 335
2025
Q4
$1.97K Buy
12
+8
+200% +$1.25K ﹤0.01% 343
2025
Q3
$535 Sell
4
-10
-71% -$1.22K ﹤0.01% 459
2025
Q2
$1.74K Buy
+14
New +$1.78K ﹤0.01% 398

Other funds holding RGEN

S&T Bank's RGEN Position: Q2 2026 in Review

S&T Bank increased its Repligen (RGEN) stake by 5.6% in Q2 2026, buying an estimated $246 and bringing the position to 38 shares worth $5.18K. The position accounts for ﹤0.01% of the portfolio, ranked #339.

S&T Bank first reported a position in RGEN in Q2 2025 and has held it in 5 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • S&T Bank held 38 shares of Repligen worth $5.18K as of Q2 2026.
  • S&T Bank bought 2 Repligen shares in Q2 2026, an estimated $246.
  • Repligen made up ﹤0.01% of S&T Bank's portfolio in Q2 2026, its #339 holding.
  • S&T Bank first reported a position in Repligen in Q2 2025 and has held it in 5 quarters since.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on S&T Bank's 13F filing for Q2 2026, filed 12 Aug 2026.